Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents
Author： Le Tourneau Christophe
Publisher： Springer Publishing Company
ISSN： 1776-2596
Source： Targeted Oncology, Vol.5, Iss.1, 2010-03, pp. : 65-72
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
